Acyclic N-halamine-immobilized polyurethane: Preparation and antimicrobial and biofilm-controlling functions
Source abstract
Abstract
Hydroxyl groups were introduced onto polyurethane surfaces through 1,6-hexamethylene diisocyanate activation, followed by diethanolamine hydroxylation. Polymethacrylamide was covalently attached to the hydroxylated polyurethane through surface grafting polymerization of methacrylamide using cerium (IV) ammonium nitrate as an initiator. After bleach treatment, the amide groups of the covalently bound polymethacrylamide chains were transformed into N-halamines. The new N-halamine-immobilized polyurethane provided a total sacrifice of 10 7 −10 8 colony forming units per milliliter of Staphylococcus aureus (Gram-positive bacteria), Escherichia coli (Gram-negative bacteria), and Candida albicans (fungi) within 10 min and successfully prevented bacterial and fungal biofilm formation. The antimicrobial and biofilm-controlling effects were both durable and rechargeable, pointing to great potentials of the new acyclic N-halamine-immobilized polyurethane for a broad range of related applications.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Antimicrobial agents and applications · Bacterial biofilms and quorum sensing · Antimicrobial Peptides and Activities
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Chemistry, University of Massachusetts Lowell, Lowell, MA, USA
Department of Comprehensive Dentistry, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA
References (28)
Show source-provided references
1. 10.1201/978148227398410.1201/9781482273984 ↗
2. Lelah MD · 1986
3. 10.1016/0141-3910(91)90080-B10.1016/0141-3910(91)90080-B ↗
4. 10.1097/00003246-199905000-0002010.1097/00003246-199905000-00020 ↗
5. 10.1038/nrmicro82110.1038/nrmicro821 ↗
6. 10.1128/MR.54.1.75-87.199010.1128/MR.54.1.75-87.1990 ↗
7. 10.2165/00003495-200565020-0000310.2165/00003495-200565020-00003 ↗
8. 10.1385/159259224410.1385/1592592244 ↗
9. 10.1088/1748-6041/3/3/03400310.1088/1748-6041/3/3/034003 ↗
10. 10.1007/BF0156999610.1007/BF01569996 ↗
11. 10.1016/j.memsci.2006.11.05410.1016/j.memsci.2006.11.054 ↗
12. 10.1016/j.biomaterials.2005.08.03810.1016/j.biomaterials.2005.08.038 ↗
13. 10.1016/S0142-9612(00)00412-910.1016/S0142-9612(00)00412-9 ↗
14. Sun YY · J Biomed Mater Res A · 2006 · 77 · 823
15. 10.1177/088391150935998010.1177/0883911509359980 ↗
16. 10.1080/1064338880938834510.1080/10643388809388345 ↗
17. 10.1177/08839115990140030510.1177/088391159901400305 ↗
18. 10.1021/am800157a10.1021/am800157a ↗
19. 10.1021/ie800139y10.1021/ie800139y ↗
20. 10.1016/j.actbio.2011.12.02710.1016/j.actbio.2011.12.027 ↗
21. 10.1002/jbm.a.3130110.1002/jbm.a.31301 ↗
22. 10.1016/j.biomaterials.2006.12.00110.1016/j.biomaterials.2006.12.001 ↗
23. 10.1002/pola.2146510.1002/pola.21465 ↗
24. 10.1016/0032-3861(94)90316-610.1016/0032-3861(94)90316-6 ↗
25. 10.1002/pola.2027010.1002/pola.20270 ↗
26. Richmond JY · 1999
27. 10.1002/jbm.a.3012510.1002/jbm.a.30125 ↗
28. 10.1163/15685620074384110.1163/156856200743841 ↗